YSM Dean's Workshop: "Vaccine Initiatives at Yale"
This workshop introduces the new vaccine initiatives network, which brings together researchers and other partners spanning biological, clinical, and public health sciences who are committed to improving population health through vaccination.
The workshop will highlight vaccine programs from the interdisciplinary network to catalyze interest and synergies across the University. It includes a keynote address from our former colleague Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration. Dr. Marks is overseeing the FDA review process for coronavirus vaccine candidates.
Sponsored by the Office of the Dean, Yale School of Medicine.
Program details are online at medicine.yale.edu/about/deanoffice/workshop.
Dean’s Workshop Contact: email@example.com
Please click the link below to join the webinar: https://zoom.us/j/844023777
Link available day of workshop at 12:30 PM.
This workshop hosted by the School of Medicine Dean’s office introduces the new Network for Vaccine Initiatives at Yale. The focus of the program is to present the breadth of vaccine research occurring across Yale, and to identify synergies across programs and foster collaboration. The workshop highlights multidisciplinary groups across campus including basic science, clinical research, and social, behavioral, and policy work. The ultimate goal is to collaborate and innovate on vaccine work at Yale to maximize the public health benefit of safe and effective vaccines around the world.
- Introduce the Network for Vaccine Initiatives at Yale as a new program to support rigorous and collaborative vaccine research at Yale.
- Describe current vaccine research at Yale spanning basic, clinical, and public health spheres.
- Identify synergistic opportunities for multidisciplinary collaboration to address pressing research questions about vaccines
ACCREDITATION STATEMENT Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
DESIGNATION STATEMENT Yale School of Medicine designates this live activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Food and Drug AdministrationPeter Marks MD, PhDDirector, Center for Biologics Evaluation and Research (CBER)